Answers are grounded in this paper and cite their sources.
The development and implementation of a robust process for the manufacture of metric ton quantities of the α2δ ligand imagabalin hydrochloride 4 is described. Key aspects of the synthesis include a chromatography-free, two-step telescoped process to prepare a mixture of Z: E -enamides 7 followed by a robust asymmetric hydrogenation with the rhodium-trichickenfootphos catalyst 8 to install the (3 S )-stereocentre. Hydrolysis of the acetamide and ester protecting groups in the final step followed by isolation and recrystallisation of the hydrochloride salt gave high purity 4 in 40–50% overall yields.
No takes yet. Share an insight, caveat, or question.
Birch et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: